-
1
-
-
0025247125
-
Hepatic injury induced by bile salts: Correlation between biochemical and morphological events
-
Schmucker DL, Ohta M, Kanai S, et al: Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990; 12:1216-1221
-
(1990)
Hepatology
, vol.12
, pp. 1216-1221
-
-
Schmucker, D.L.1
Ohta, M.2
Kanai, S.3
-
2
-
-
0022656312
-
Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids
-
Attili AF, Angelico M, Canagora A, et al: Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986; 19:57-69
-
(1986)
Med Hypotheses
, vol.19
, pp. 57-69
-
-
Attili, A.F.1
Angelico, M.2
Canagora, A.3
-
3
-
-
0012571630
-
The effect of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocyte and erythrocyte membranes
-
Lim AG, Ahmed HA, Jazrawi RP, et al: The effect of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocyte and erythrocyte membranes. Gut 1993; 34:45-49
-
(1993)
Gut
, vol.34
, pp. 45-49
-
-
Lim, A.G.1
Ahmed, H.A.2
Jazrawi, R.P.3
-
4
-
-
0342662084
-
Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat
-
Kitani K, Ohta M, Kanai S: Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985; 248:G407-G417
-
(1985)
Am J Physiol
, vol.248
-
-
Kitani, K.1
Ohta, M.2
Kanai, S.3
-
5
-
-
0028351832
-
Ursodeoxycholate conjugates protects against disruption of cholesterol-rich membranes by bile salts
-
Heuman DM, Bajaj R: Ursodeoxycholate conjugates protects against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 1994; 106:1333-1341
-
(1994)
Gastroenterology
, vol.106
, pp. 1333-1341
-
-
Heuman, D.M.1
Bajaj, R.2
-
6
-
-
0012618953
-
Ursodiol in the long-term treatment of chronic hepatitis C: A randomized clinical trial with long-term follow-up
-
Bellentani S, Podda M, Tiribelli C, et al: Ursodiol in the long-term treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up. Am J Gastroenterol 1995; 90:263-269
-
(1995)
Am J Gastroenterol
, vol.90
, pp. 263-269
-
-
Bellentani, S.1
Podda, M.2
Tiribelli, C.3
-
7
-
-
0025876404
-
A multicenter, controlled trial of ursodiol for the treatment of primary billary cirrhosis
-
UDCA-PBC Study Group
-
Poupon RE, Balkau B, Eschwege E, et al: A multicenter, controlled trial of ursodiol for the treatment of primary billary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991; 324:1548-1554
-
(1991)
N Engl J Med
, vol.324
, pp. 1548-1554
-
-
Poupon, R.E.1
Balkau, B.2
Eschwege, E.3
-
8
-
-
0031047361
-
Ursodiol for primary sclerosing cholangitis
-
Lindor KD: Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336:691-695
-
(1997)
N Engl J Med
, vol.336
, pp. 691-695
-
-
Lindor, K.D.1
-
9
-
-
0014021207
-
Cholestasis in rats induced by taurolithocholate
-
Javitt JB: Cholestasis in rats induced by taurolithocholate. Nature 1966; 210:599-604
-
(1966)
Nature
, vol.210
, pp. 599-604
-
-
Javitt, J.B.1
-
10
-
-
0029145255
-
Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria
-
Krahenbuhl S, Talos C, Fischer S, et al: Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology 1995; 22:607-612
-
(1995)
Hepatology
, vol.22
, pp. 607-612
-
-
Krahenbuhl, S.1
Talos, C.2
Fischer, S.3
-
11
-
-
0028135420
-
Increases of intracellular magnesium promotes glycodeoxycholate-induced apoptosis in rat hepatocytes
-
Patel T, Bronk SF, Gores GJ: Increases of intracellular magnesium promotes glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94:2183-2192
-
(1994)
J Clin Invest
, vol.94
, pp. 2183-2192
-
-
Patel, T.1
Bronk, S.F.2
Gores, G.J.3
-
12
-
-
0025098908
-
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid
-
Calmus Y, Gane P, Rouger P, et al: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatologv 1990; 11:12-15
-
(1990)
Hepatologv
, vol.11
, pp. 12-15
-
-
Calmus, Y.1
Gane, P.2
Rouger, P.3
-
13
-
-
0020318866
-
Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis
-
Bachrach WH, Hofmann AF: Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci 1982; 24:737-762,833-858
-
(1982)
Dig Dis Sci
, vol.24
, pp. 737-762
-
-
Bachrach, W.H.1
Hofmann, A.F.2
-
14
-
-
0022397043
-
Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man
-
Parquet M, Metman EH, Raizman A, et al: Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man. Eur J Clin Invest 1985; 15:171-178
-
(1985)
Eur J Clin Invest
, vol.15
, pp. 171-178
-
-
Parquet, M.1
Metman, E.H.2
Raizman, A.3
-
15
-
-
0031770301
-
Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications
-
Beuers U, Boyer JL, Paumgartner G: Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology 1998; 28:1449-1453
-
(1998)
Hepatology
, vol.28
, pp. 1449-1453
-
-
Beuers, U.1
Boyer, J.L.2
Paumgartner, G.3
-
16
-
-
0030926783
-
Bile acid therapy in pediatric hepatobiliary disease: The role of ursodeoxycholic acid
-
Balistreri WF: Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastro Nutrit 1997; 24:573-589
-
(1997)
J Pediatr Gastro Nutrit
, vol.24
, pp. 573-589
-
-
Balistreri, W.F.1
-
17
-
-
0029084112
-
Stability of ursodiol in an extemporaneously compounded oral liquid
-
Johnson CE, Nesbitt J: Stability of ursodiol in an extemporaneously compounded oral liquid. Am J Health Syst Pharm 1995; 52:1798-1800
-
(1995)
Am J Health Syst Pharm
, vol.52
, pp. 1798-1800
-
-
Johnson, C.E.1
Nesbitt, J.2
|